Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors
The need for new drugs is compelling, irrespective of the disease. Focusing on medical problems in the Western countries, heart disease and cancer are at the moment predominant illnesses. Owing to the fact that ~90% of all 21,000 cellular proteins in humans are regulated by phosphorylation/dephospho...
Main Authors: | Barbara Guerra, Olaf-Georg Issinger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/12/1/4 |
Similar Items
-
Molecular Basis for Ser/Thr Specificity in PKA Signaling
by: Matthias J. Knape, et al.
Published: (2020-06-01) -
Structural and Evolutionary Analyses of Signalling Proteins with Special Reference to Protein Kinases
by: Rakshambikai, R
Published: (2018) -
Exploiting holistic approaches to model specificity in protein phosphorylation
by: Antonio ePalmeri, et al.
Published: (2014-09-01) -
Compound C, a Broad Kinase Inhibitor Alters Metabolic Fingerprinting of Extra Cellular Matrix Detached Cancer Cells
by: Mohammed Razeeth Shait Mohammed, et al.
Published: (2021-02-01) -
Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
by: D. Samuel Metibemu, et al.
Published: (2019-12-01)